Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sucampo Pharmaceuticals, a specialty biopharmaceutical company, has appointed Gayle Dolecek to its board of directors.
Subscribe to our email newsletter
Dr Dolecek is currently Sucampo’s senior vice president of R&D. Dr Dolecek has received his BS from the University of Maryland and a MPH in health services and planning from the University of Hawaii.
Ryuji Ueno, chairman and CEO of Sucampo, said: “Gayle has worked with Sucampo since its founding, first as a consultant and now as head of R&D. His expertise has also been instrumental in the regulatory submissions for Amitiza in Europe.
“Gayle’s considerable R&D experience have been vital in the continued progress of Sucampo’s earlier stage programs, which are likely to be a key component of our long term growth. We believe that Gayle will continue to bring valuable insight to the board.”